Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidACHDASDcoarctationtetralogy of FallotEisenmenger syndromepregnancy
Congenital heart disease in adults
Essential points for quick revision.
2 min synopsisUK scopeSources checked 25 Aug 2026Clinical review pending
!
Escalate
New cyanosis, syncope, sustained arrhythmia, decompensated heart failure, chest pain, haemoptysis, neurological deficit or suspected endocarditis in an adult with congenital heart disease warrants urgent hospital assessment and early contact with the regional ACHD centre. Sudden blue/grey colour with breathing difficulty, chest pain, confusion, dizziness or rapid/irregular heartbeat is a 999 emergency.
Synopsis
Recognise repaired and unrepaired congenital heart disease, identify ACHD emergencies and pregnancy risk, and route lesion-specific surveillance and intervention through specialist services.
Never assume childhood repair equals cure: residual shunts, valve disease, ventricular dysfunction, aortopathy, pulmonary hypertension and scar-related arrhythmia may emerge decades later.
Identify the exact anatomy, operations/interventions, ventricular physiology, shunts/conduits, devices, baseline saturation and usual ECG before interpreting acute findings.
Transthoracic echo is first-line; CMR is central for right-ventricular volumes, flows and extracardiac anatomy, while CT helps with coronary arteries, conduits, calcification and stent detail.
Key red flags
Acute deterioration
New cyanosis below baseline, syncope, sustained tachyarrhythmia/bradyarrhythmia, pulmonary oedema, low-output state, haemoptysis, focal neurology or fever with possible endocarditis.
Investigation priorities
01
Retrieve operative/interventional records, baseline ECG and saturationFirst step
Define anatomy and the patient's normal physiology before labelling a new abnormality.
02
Transthoracic echocardiographyFirst line
First-line assessment of anatomy, ventricular function, valves, gradients, shunts and estimated pulmonary pressure.
New cyanosis, syncope, arrhythmia, heart failure, chest pain, haemoptysis, neurological deficit or sepsis.
Use ABCDE, monitoring, 12-lead ECG, IV access and syndrome-directed resuscitation while contacting the regional ACHD centre early; retrieve the anatomy/operation record and baseline saturation.
Use meticulous air-free IV technique and filters when a right-to-left shunt is possible. Avoid abrupt preload loss or systemic vasodilation in Fontan/cyanotic physiology without expert advice.
Key medicines
Aspirin after ASD device closure75 mg orally once daily for at least 6 months after device closure, unless the interventional ACHD plan specifies otherwise.
Bosentan62.5 mg orally twice daily for 4 weeks, then 125 mg twice daily if tolerated.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 25 Aug 2026; clinical approval remains outstanding.